What Alteon Inc does

Alteon Inc is a privately held for-profit biotechnology company headquartered in Parsippany, New Jersey, United States. According to available firmographic data, the company was founded in 1986 and operates with a headcount of 11-50 employees. Its sector classification is biotechnology; however, no specific therapeutic focus, pipeline assets, modality, or platform technology was disclosed in the source material.

The company's substantive product, technology, and commercial profile could not be verified from the inputs provided. The corporate website (alteon.com) was inaccessible at the time of data collection, returning only a browser verification/captcha page, and no product/service descriptions, patents, partnerships, customer references, pricing, or distribution-channel information were captured. As a result, the company's business model, go-to-market approach, and revenue mechanics cannot be characterized from this data set.

For diligence purposes, the only first-party-verifiable attributes are: legal entity type (private for-profit), founding year (1986), employee band (11-50), HQ location (Parsippany, NJ, US), and sector tag (biotechnology). Any further characterization of what Alteon Inc builds, sells, or to whom requires direct company outreach or primary-source verification beyond the data supplied.

Name

Alteon Inc

Website

https://www.alteon.com/

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

Alteon Inc is a privately held US biotechnology company founded in 1986, headquartered in Parsippany, New Jersey, with 11-50 employees. Its specific therapeutic focus, pipeline, and commercial model are not disclosed in available source data.

Ownership category

akta.pro rank

Product category

Biotechnology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Therapeutic Enzymes & Enzyme Replacement Therapies (ERT) (HLAAAAAK)

Keywords

• Biotechnology research
• Therapeutic development
• Life sciences
• Biotech company
• Biopharmaceutical research

Headquarters

HQ city

Parsippany

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Core offering

Alteon Inc is identified in the available source material as a privately held biotechnology company founded in 1986 and headquartered in Parsippany, United States. No specific products, services, therapeutic candidates, or scientific programs are documented because the only accessible web source (http://alteon.com/) returned a browser verification screen without substantive company content.

Differentiator

Problem solved

Functional benefit

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Direct peers

• vTv Therapeutics: vTv Therapeutics is a small clinical-stage biopharmaceutical company developing oral therapeutics for metabolic and inflammatory diseases. It is comparable to Alteon as a similarly sized clinical-stage biotech with limited headcount pursuing chronic-disease therapeutics.
• Ovid Therapeutics: Ovid Therapeutics is a small clinical-stage biopharmaceutical company focused on neurological and rare diseases. It is comparable to Alteon through its similarly constrained headcount and clinical-stage operating profile.
• Capricor Therapeutics: Capricor Therapeutics is a clinical-stage biotechnology company developing cell and exosome-based therapeutics for rare diseases. It is comparable to Alteon as a similarly small clinical-stage biotech operating with a lean team across multiple development activities.

Emerging players

• Arcturus Therapeutics: Arcturus Therapeutics is a clinical-stage biotechnology company developing nucleic-acid-based therapeutics for rare and metabolic diseases. It is comparable to Alteon as a small clinical-stage biotech pursuing therapeutic indications with comparable headcount and capital profile.
• TG Therapeutics: TG Therapeutics is a biopharmaceutical company developing therapies for B-cell mediated diseases. While its therapeutic focus differs, it is comparable to Alteon as a New Jersey-based biotech with a similar small- to mid-cap operating footprint.
• Aprea Therapeutics: Aprea Therapeutics is a clinical-stage biopharmaceutical company developing novel cancer therapies targeting the p53 pathway. It is comparable to Alteon as a similarly small clinical-stage biotech with a constrained operating profile and limited disclosed pipeline visibility.

Broad incumbents

• Madrigal Pharmaceuticals: Madrigal Pharmaceuticals is a biopharmaceutical company focused on cardio-metabolic and liver diseases. It is comparable to Alteon through overlapping metabolic-disease therapeutic area, though operating at materially greater scale and capitalization.
• Esperion Therapeutics: Esperion Therapeutics is a pharmaceutical company developing and commercializing oral therapies for elevated LDL-C and cardiometabolic risk. It is comparable to Alteon through its cardiometabolic therapeutic focus, though it operates at a significantly larger and more advanced commercial scale.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks3 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alteon Inc